No Matches Found
No Matches Found
No Matches Found
Mativ Holdings, Inc.
Is Mativ Holdings, Inc. overvalued or undervalued?
As of February 22, 2023, Mativ Holdings, Inc. is considered overvalued and risky due to poor financial metrics, including a low ROCE of 2.14%, negative ROE of -2.59%, and a year-to-date stock decline of 41.65%, significantly underperforming its peers and the S&P 500.
Is Mativ Holdings, Inc. technically bullish or bearish?
As of May 8, 2025, Mativ Holdings, Inc. shows a mildly bearish trend due to daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly timeframe, suggesting limited upside potential in the near term.
Who are in the management team of Mativ Holdings, Inc.?
As of March 2022, the management team of Mativ Holdings, Inc. includes Non-Executive Independent Chairman Mr. John Rogers, CEO Dr. Jeffrey Kramer, and Independent Directors Ms. Deborah Borg, Mr. Mark Bye, Mr. Jeffrey Keenan, and Dr. Marco Levi.
What does Mativ Holdings, Inc. do?
Mativ Holdings, Inc. is a diversified producer in the specialty chemicals industry, focusing on engineered papers and advanced materials. As of March 2025, it reported net sales of $485 million and a net profit loss of $426 million, with a market cap of $355.11 million.
How big is Mativ Holdings, Inc.?
As of Jun 18, Mativ Holdings, Inc. has a market capitalization of 355.11 million and reported net sales of 1,965.70 million with a net profit of -446.60 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

